Abstract:Background: Ascomycin is a 23-membered polyketide macrolide with high immunosuppressant and antifungal activity. As the lower production in bio-fermentation, global metabolic analysis is required to further explore its bio-synthetic network and determine the key limiting steps for rationally engineering. To achieve this goal, an engineering approach guided by a metabolic network model was implemented to better understand ascomycin biosynthesis and improve its production. Results: The metabolic conservation of Streptomyces species was first investigated by comparing the metabolic enzymes of Streptomyces coelicolor A3(2) with those of 31 Streptomyces strains, the results showed that more than 72% of the examined proteins had high sequence similarity with counterparts in every surveyed strain. And it was found that metabolic reactions are more highly conserved than the enzymes themselves because of its lower diversity of metabolic functions than that of genes. The main source of the observed metabolic differences was from the diversity of secondary metabolism. According to the high conservation of primary metabolic reactions in Streptomyces species, the metabolic network model of Streptomyces hygroscopicus var. ascomyceticus was constructed based on the latest reported metabolic model of S. coelicolor A3(2) and validated experimentally. By coupling with flux balance analysis and using minimization of metabolic adjustment algorithm, potential targets for ascomycin overproduction were predicted. Since several of the preferred targets were highly associated with ethylmalonyl-CoA biosynthesis, two target genes hcd (encoding 3-hydroxybutyryl-CoA dehydrogenase) and ccr (encoding crotonyl-CoA carboxylase/reductase) were selected for overexpression in S. hygroscopicus var. ascomyceticus FS35. Both the mutants HA-Hcd and HA-Ccr showed higher ascomycin titer, which was consistent with the model predictions. Furthermore, the combined effects of the two genes were evaluated and the strain HA-Hcd-Ccr with hcd and ccr overexpression exhibited the highest ascomycin production (up to 438.95 mg/L), 1.43-folds improvement than that of the parent strain FS35 (305.56 mg/L). Conclusions: The successful constructing and experimental validation of the metabolic model of S. hygroscopicus var. ascomyceticus showed that the general metabolic network model of Streptomyces species could be used to analyze the intracellular metabolism and predict the potential key limiting steps for target metabolites overproduction. The corresponding overexpression strains of the two identified genes (hcd and ccr) using the constructed model all displayed higher ascomycin titer. The strategy for yield improvement developed here could also be extended to the improvement of other secondary metabolites in Streptomyces species.

A Computational Metabolic Model for Engineered Production of Resveratrol in Escherichia coli

Optimization of Biosynthetical Conditions of Resveratrol with Recombinant Escherichia coli

Efficient de novo synthesis of resveratrol by metabolically engineered Escherichia coli

De novo resveratrol production through modular engineering of an Escherichia coli–Saccharomyces cerevisiae co-culture

Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol

Genomic sequencing, genome-scale metabolic network reconstruction, and in silico flux analysis of the grape endophytic fungus Alternaria sp. MG1

Investigating E. coli Coculture for Resveratrol Production with 13C Metabolic Flux Analysis

Synthetic Biology-Driven Microbial Production of Resveratrol: Advances and Perspectives

De Novo Synthesis of Resveratrol from Sucrose by Metabolically Engineered Yarrowia lipolytica

Engineering the oleaginous yeast Yarrowia lipolytica for high-level resveratrol production

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Remodelling metabolism for high-level resveratrol production in Yarrowia lipolytica

Heterologous biosynthesis of prenylated resveratrol through multiplex metabolic engineering in Escherichia coli

Model-driven intracellular redox status modulation for increasing isobutanol production in Escherichia coli

Analysis of metabolic networks of Streptomyces leeuwenhoekii C34 by means of a genome scale model: Prediction of modifications that enhance the production of specialized metabolites

Biotechnological Advances in Resveratrol Production and its Chemical Diversity

Combinatorial Metabolic Engineering of <i>Escherichia coli</i> for Enhanced L-Cysteine Production: Insights into Crucial Regulatory Modes and Optimization of Carbon-Sulfur Metabolism and Cofactor Availability

An Optimum Fermentation Model Established by Genetic Algorithm for Biotransformation from Crude Polydatin to Resveratrol

Redesign and reconstruction of a steviol-biosynthetic pathway for enhanced production of steviol in Escherichia coli

Metabolic Network Model Guided Engineering Ethylmalonyl-Coa Pathway to Improve Ascomycin Production in Streptomyces Hygroscopicus Var. Ascomyceticus.

Enhancement of Rapamycin Production by Metabolic Engineering in Streptomyces Hygroscopicus Based on Genome-Scale Metabolic Model